Related references
Note: Only part of the references are listed.GPS 5.0: An Update on the Prediction of Kinase-specific Phosphorylation Sites in Proteins
Chenwei Wang et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2020)
RNA-binding proteins in tumor progression
Hai Qin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription
Rui Xiao et al.
CELL (2019)
ATM in DNA repair in cancer
Mei Hua Jin et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Understanding p53 functions through p53 antibodies
Kanaga Sabapathy et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Mutational processes shape the landscape of TP53 mutations in human cancer
Andrew O. Giacomelli et al.
NATURE GENETICS (2018)
Nucleolar Stress: hallmarks, sensing mechanism and diseases
Kai Yang et al.
CELL STRESS (2018)
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
Myron G. Best et al.
CANCER CELL (2017)
RNA-Binding Proteins in Cancer: Old Players and New Actors
Bruno Pereira et al.
TRENDS IN CANCER (2017)
Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks
Endre Sebestyen et al.
GENOME RESEARCH (2016)
The relationship between the nucleolus and cancer: Current evidence and emerging paradigms
Ines Orsolic et al.
SEMINARS IN CANCER BIOLOGY (2016)
A redox mechanism underlying nucleolar stress sensing by nucleophosmin
Kai Yang et al.
NATURE COMMUNICATIONS (2016)
The molecular basis for ANE syndrome revealed by the large ribosomal subunit processome interactome
Kathleen L. McCann et al.
ELIFE (2016)
RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance
Yong Liu et al.
TRENDS IN CANCER (2016)
p53 and ribosome biogenesis stress: The essentials
Lior Golomb et al.
FEBS LETTERS (2014)
RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation
Ming Yuan et al.
ONCOTARGET (2014)
p53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapy
B. Rao et al.
BRITISH JOURNAL OF CANCER (2013)
DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
Kahlin Cheung-Ong et al.
CHEMISTRY & BIOLOGY (2013)
Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses
S. Lee et al.
CELL DEATH AND DIFFERENTIATION (2012)
Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
P. T. Ferrao et al.
ONCOGENE (2012)
Computer-based fluorescence quantification: a novel approach to study nucleolar biology
Mohamed Kodiha et al.
BMC CELL BIOLOGY (2011)
ANE syndrome caused by mutated RBM28 gene: a novel etiology of combined pituitary hormone deficiency
Ronen Spiegel et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
The Nucleolus under Stress
Severine Boulon et al.
MOLECULAR CELL (2010)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
Alopecia, neurological defects, and endocrinopathy syndrome caused by decreased expression of RBM28, a nucleolar protein associated with ribosome biogenesis
Janna Nousbeck et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics
Zehan Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Human RBM28 protein is a specific nucleolar component of the spliceosomal snRNPs
Andrey Damianov et al.
BIOLOGICAL CHEMISTRY (2006)
Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21Waf1/Cip1
Y Zhao et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
RNA Binding Motif (RBM) proteins: A novel family of apoptosis modulators?
LC Sutherland et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Share Paper
